Literature DB >> 2502802

A review of PCP abuse trends and perceptions.

D L Thombs1.   

Abstract

A critical review of epidemiologic literature on the abuse of phencyclidine (PCP) suggests that current perceptions by the public and among members of the health professions and drug treatment communities about abuse of the drug are distorted. Epidemiologic data indicate that PCP abuse is not widespread in the United States, nor is its abuse prevalent among adolescents. Its abuse has become concentrated among post-high school age, black males in a limited number of cities, especially Washington, DC. The degree of PCP abuse in a metropolitan area may be related to the availability and cost of other, more highly coveted drugs, such as crack cocaine.

Entities:  

Mesh:

Year:  1989        PMID: 2502802      PMCID: PMC1579931     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  4 in total

1.  Use of phencyclidine among adolescents attending a suburban drug treatment facility.

Authors:  R H Schwartz; N G Hoffmann; D Smith; G F Hayden; M Riddile
Journal:  J Pediatr       Date:  1987-02       Impact factor: 4.406

2.  PCP abuse in New Orleans: a six-year study.

Authors:  R E Garey; G C Daul; M S Samuels; F A Ragan; S A Hite
Journal:  Am J Drug Alcohol Abuse       Date:  1987       Impact factor: 3.829

Review 3.  The PCP epidemic: a critical review.

Authors:  B L Davis
Journal:  Int J Addict       Date:  1982-10

4.  Phencyclidine (PCP) abuse. A close-up look at a growing problem.

Authors:  S O Isaacs; P Martin; J A Washington
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1986-02
  4 in total
  1 in total

1.  Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.

Authors:  Matthew D Krasowski; Anthony F Pizon; Mohamed G Siam; Spiros Giannoutsos; Manisha Iyer; Sean Ekins
Journal:  BMC Emerg Med       Date:  2009-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.